by William A. Haseltine - Forbes Induced pluripotent stem cells (iPSC), a continuing muse in cell therapy research, could potentially be used to improve flaws associated with conventional CAR T therapy. What if an effective cancer treatment became cheaper and easier...

By Izzy Wood -  Drug Target Review US researchers combine revascularisation techniques to allow new blood vessels to rapidly form in an architecturally organised manner. The ability to regenerate and pattern blood vessels remains an elusive milestone in regenerative...

By Genetic and Engineering News Alzheimer’s disease (AD) is the sixth leading cause of death in the United States. However, the exact cause of AD remains unknown. Existing approved treatments for AD are designed to target the already existing AD neuropathology,...

By McMaster University McMaster researchers have uncovered a fast and effective way to detect cancer stem cells before the disease recurs in adults who previously underwent treatment. Mick Bhatia, a professor in the department of Biochemistry and Biomedical Sciences,...

By Michael Irving - New Atlas Yale scientists have discovered a new potential treatment avenue to fight cancer. Using CRISPR gene-editing, the team eliminated extra chromosomes from cancer cells and found that they could no longer grow out of control. Healthy human...

By Anna Lazarus Caplan - People It was just after his eighth birthday when Hanif Mouehla found himself fighting for his life after being diagnosed with sickle cell disease. Inspired by the care he received, the 17-year-old is now eyeing the pre-med track at Harvard...

by Mrigakshi Dixit - Interesting Engineering Named Lantidra, it's a cellular therapy developed using deceased donor pancreatic cells for the treatment of type 1 diabetes in adults. Therapy suitable for patients with hypoglycemia Type 1 diabetes makes the pancreas...

By Anne Trafton | MIT News Office Engineering T cells to destroy cancer cells has shown success in treating some types of cancer, such as leukemia and lymphoma. However, it hasn’t worked as well for solid tumors. One reason for this lack of success is that the T cells...

By Ax-2 Mission Ax-2 Mission Specialist Ali Alqarni uses the Smarting Pro EEG device aboard the ISS to conduct brain studies. During Axiom Mission 2 (Ax-2), the Ax-2 astronauts measured changes in their eyes, blood pressure, blood oxygen, and heart rate levels, as...

By Stem Cells Translational Medicine READ THE JUNE ISSUE Human Clinical Article Cell-Based Drug Development, Screening, and Toxicology Enabling Technologies for Cell-Based Clinical Translations Manufacturing for Regenerative Medicine and more.... Click Here to Read...

By BlueRock Therapeutics Berlin, Germany and Cambridge, M.A., U.S.A., June 28, 2023 – Bayer AG and BlueRock Therapeutics LP, a clinical stage cell therapy company and wholly owned independently operated subsidiary of Bayer AG, today announced positive top-line results...

By Kyoto University Kyoto, Japan -- Animal experimentation may not be a thing of the past just yet, but work on human iPS cell technology may someday grant emancipation for lab mice and other species. Renal proximal tubules play a major role in our kidneys' ability to...